Pictet Asset Management (Switzerland)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $25.4M | Buy |
1,095,566
+222,228
| +25% | +$5.15M | 0.03% | 410 |
|
|
2023
Q1 | $20.3M | Buy |
873,338
+572,778
| +191% | +$13.3M | 0.03% | 454 |
|
|
2022
Q4 | $4.36M | Buy |
300,560
+78,881
| +36% | +$1.14M | 0.01% | 761 |
|
|
2022
Q3 | $4.23M | Buy |
221,679
+48,269
| +28% | +$921K | 0.01% | 768 |
|
|
2022
Q2 | $3.15M | Buy |
173,410
+10,615
| +7% | +$193K | ﹤0.01% | 854 |
|
|
2022
Q1 | $4.1M | Sell |
162,795
-3,939
| -2% | -$99.3K | ﹤0.01% | 844 |
|
|
2021
Q4 | $4.6M | Sell |
166,734
-34,642
| -17% | -$956K | ﹤0.01% | 846 |
|
|
2021
Q3 | $6.5M | Buy |
+201,376
| New | +$6.5M | 0.01% | 782 |
|